SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 3, 2026

TRDA

Entrada Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $1.6M total
Actionable Insight • Neutral

The selling is concentrated in a director and a venture capital holder, which may reflect portfolio rebalancing or a 10b5-1 plan rather than a negative view on the company. Monitor for any subsequent filings (e.g., Form 144 or 8-K) that could indicate a broader sell-off or material news. Given the strong analyst consensus and lack of insider buying, the stock is likely to trade on fundamentals rather than this insider activity.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$7.24
T+0 close · Aug 3, 2026 · via day close
Latest settled
−39.09%
T+60 · $4.41
Vs SPY
−38.87%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 4 $7.24entry
  2. T+1 · 3mo ago −2.49%α −2.29% · $7.06
  3. T+5 · 3mo ago −2.76%α −2.66% · $7.04
  4. T+20 · 3mo ago −2.35%α −1.11% · $7.07
  5. T+60 · 20d ago −39.09%α −38.87% · $4.41
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Entrada Therapeutics (Director Kush Parmar and 10% owner 5AM Ventures) sold a combined $1.59M in open-market sales over two days, representing ~0.6% of the company's $264M market cap. This is a significant cluster of selling by a director and a major venture holder, but the dollar amount is modest relative to market cap and the sales are likely part of a pre-arranged plan or liquidity event rather than a bearish signal. The stock has a strong analyst consensus (86% bullish) and recent insider activity includes $1.6M in sales over 30 days, suggesting a pattern of routine selling rather than a new negative development.

Key Financial Metrics

Direction
selling
Total Value
$1.6M
Insiders
2

Key Facts

  • Director Kush Parmar sold 114,756 shares at $6.93 on 2026-07-30 for $795K
  • 5AM Ventures V, L.P. sold 114,756 shares at $6.93 on 2026-07-30 for $795K
  • Total cluster value: $1.59M, representing ~0.6% of $264M market cap
  • Both insiders also sold 1,718 shares each at $6.85 on 2026-07-31 for ~$11.8K total
  • Net direction is selling; no insider buying in the cluster

Financial Impact

Insider sales of $1.59M represent ~0.6% of market cap, a modest but notable amount

insider ownershipdilution

Risk Factors

  • Continued insider selling could signal lack of confidence if it accelerates
  • Venture capital selling may pressure the stock if not absorbed by institutional demand
  • No insider buying to offset the selling pattern

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TRDA-1785814363438

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 3, 2026